Videos

Amanda Williams, MD, MPH, FACOG, Interim Chief Medical Officer at March of Dimes, discusses the reported increase in the number of US counties with no obstetric care providers.

In this episode, clinicians discuss challenges associated with these topics and offer some insights on them.

Jean Dubuisson, MD, PhD, head of the gynecological surgery unit at Geneva University Hospitals, discusses the first successful hysterectomy performed using the MIRA surgical system.

A study discussed by Tabby Khan, MD. MPH, reveals low rates of low-dose aspirin use among high-risk preeclampsia patients, highlighting the need for increased clinician awareness and better insurance coverage to improve maternal and infant health outcomes.

Kristyn Brandi, MD, MPH, FACOG, discusses the Supreme Court's decision to maintain mifepristone availability and its potential impact on future women's health cases.

In an interview with Contemporary OB/GYN, Bianca Hall, DO, MSCR, discusses the Supreme Court’s decision affirming mifepristone's safety and accessibility, emphasizing its role in providing comprehensive abortion care.

Risa Kagan, MD, discusses the efficacy of fezolinetant in reducing the frequency and severity of vasomotor symptoms in menopausal women, offering an alternative to traditional hormonal therapies.

Wanda Barfield, MD, MPH, highlights significant racial disparities in maternal mortality and emphasizes the importance of collaborative efforts and data-driven approaches to improve maternal health outcomes in the United States.

Mary Claire B. Manske, MD, discusses her findings on the unexplained increased risk of brachial plexus birth injury among Black and Hispanic infants, highlighting the need for improved prenatal care and further research.

A symposium at ACOG 2024 focused on how to boost clinician confidence when it comes to contraception education for this patient population.

Experts discuss the necessity of evolving prenatal care through innovative models to better meet patient needs and incorporate advances such as telemedicine.

Dive into the research presented by Rhonda R. Voskuhl at ACOG 2024, shedding light on the potential of estrogen receptor beta as a target to mitigate cognitive decline in postmenopausal women.

At ACOG 2024, Monica M. Christmas, MD, FACOG, and Stephanie Faubion, MD, emphasize the importance of combating disinformation in menopause care and provide clinicians with evidence-based strategies to manage symptoms effectively.

Raanan Meyer, MD, shares the results and takeaways from his ACOG 2024 study on a 24-hour compared with 12-hour mifepristone-misoprostol regimen for second-trimester abortion, including the impact on patient satisfaction.

At the 2024 ACOG Annual Clinical & Scientific Meeting, experts emphasized the importance of equipping ob-gyns with the knowledge and tools to address sexual health issues, including hyperactive sexual desire disorder, anorgasmia, and pelvic pain.

Phase 3 data presented by JoAnn Pinkerton, MD, reveals that elinzanetant significantly improves hot flash frequency, sleep, and overall menopause quality of life, offering a promising alternative to estrogen therapy.

Alison Edelman, MD, MPH, dives into her research presented at the 2024 ACOG Annual Clinical and Scientific Meeting on COVID-19 vaccination and it's impact on the menstrual cycle.

Leanne R. McCloskey, MD, and Weronika A. Armstrong, MD, xplore the multifaceted applications of misoprostol in obstetrics, covering protocols, safety, and the impact on birth equity from early pregnancy loss to labor induction at ACOG 2024.

In this video interview, Jamila Perritt, MD, discusses her presentation at the 2024 ACOG Annual Clinical and Scientific Meeting on how ob-gyns can be an effective advocate.

Michelle Jacobson, MD, MHSc, FRCSC, shares critical perspectives on managing vasomotor symptoms in breast cancer patients at the recent ACOG Annual Clinical & Scientific Meeting, emphasizing the importance of tailored approaches amidst evolving treatment options and patient risks.

Elina Melik-Levine, ARNP, highlights the importance of early discussions about fertility preservation, referral pathways, and addressing socioeconomic challenges in cancer care, emphasizing the role of Miami Cancer Institute's onco-fertility program.

Jenell Stewart, DO, MPH, discusses her team's qualitative research into the STI prevention tendencies and interests of at-risk women.

Maternal-fetal medicine specialist Todd Rosen, MD, discusses how quitting smoking during pregnancy affects risks of preterm birth, stillbirth, and preeclampsia, urging simultaneous focus on nutrition to optimize outcomes.

The United States Preventive Services Task Force has announced new recommendations for breast cancer screenings. Find out what this means for your patients and your practice.

Discover the benefits of regular exercise during pregnancy, from reducing risks of adverse outcomes to improving psychologic symptoms, as discussed by Gabriela Dellapiana, MD, maternal-fetal medicine physician at Cedars-Sinai Medical Center.

Mitchell Creinin, MD, sheds lights on the association between combined oral contraceptives and breast cancer risk, offering valuable insights for clinicians and patients alike.

Jenell Stewart, DO, MPH, discusses the factors impacting the poor uptake of potential STI prophylaxes including doxycycline.

Learn from Paige Meizlik, MD, MSTR, about the FDA's Fast Track Designation for nipocalimab, offering hope for addressing the critical unmet needs in treating fetal neonatal alloimmune thrombocytopenia and advancing maternal-fetal immunology research.

Carolyn Kay, MD, discusses the latest ASCCP guidelines and the introduction of dual stain cytology for improved HPV detection and patient management, aiming to alleviate anxiety and enhance efficacy in cervical cancer prevention.